載入...
The promise of epigenomic therapeutics in pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC) is often viewed to arise primarily by genetic alterations. However, today we know that many aspects of the cancer phenotype require a crosstalk among these genetic alterations with epigenetic changes. Indeed, aberrant gene expression patterns, driven by epigen...
Na minha lista:
| 發表在: | Epigenomics |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Future Medicine Ltd
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5066125/ https://ncbi.nlm.nih.gov/pubmed/27337224 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/epi-2015-0016 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|